[
  {
    "ts": null,
    "headline": "Novocure Stock Earns 96 RS Rating",
    "summary": "On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study.",
    "url": "https://finnhub.io/api/news?id=9a4d2951f2d862f46917dc5bcf965537bc87553d68ba955ff64674522fa1a344",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733255460,
      "headline": "Novocure Stock Earns 96 RS Rating",
      "id": 131764608,
      "image": "https://media.zenfs.com/en/ibd.com/a0087e245354977c880d4d8274a97075",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study.",
      "url": "https://finnhub.io/api/news?id=9a4d2951f2d862f46917dc5bcf965537bc87553d68ba955ff64674522fa1a344"
    }
  }
]